Free release
17-Oxo-21-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13-tetraoxa-16-azahenic

17-Oxo-21-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13-tetraoxa-16-azahenic

CAS No. :721431-18-1MDL No. :MFCD08457831Formula :C21H37N3O8SBoiling Point :-Linear Structure Formula :-InChI Key :GYOXF

Sales:Service@apichina.com
CAS No. :721431-18-1 Brand :Qitai
Formula :C21H37N3O8S M.W :491.60

Introduction

CAS No. :721431-18-1 MDL No. :MFCD08457831
Formula : C21H37N3O8S Boiling Point : -
Linear Structure Formula :- InChI Key :GYOXFFWLRKVJJX-ZWOKBUDYSA-N
M.W : 491.60 Pubchem ID :17040189
Synonyms :
Chemical Name :17-Oxo-21-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10,13-tetraoxa-16-azahenicosanoic acid

Physicochemical Properties

Num. heavy atoms : 33
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.86
Num. rotatable bonds : 21
Num. H-bond acceptors : 8.0
Num. H-bond donors : 4.0
Molar Refractivity : 129.56
TPSA : 169.75 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -10.02 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.65
Log Po/w (XLOGP3) : -1.01
Log Po/w (WLOGP) : -0.39
Log Po/w (MLOGP) : -0.89
Log Po/w (SILICOS-IT) : 2.1
Consensus Log Po/w : 0.49

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 2.0
Egan : 1.0
Muegge : 2.0
Bioavailability Score : 0.11

Water Solubility

Log S (ESOL) : -0.87
Solubility : 67.0 mg/ml ; 0.136 mol/l
Class : Very soluble
Log S (Ali) : -2.07
Solubility : 4.2 mg/ml ; 0.00855 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.51
Solubility : 0.0153 mg/ml ; 0.0000311 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.99
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: